Home

Care Capital Offshore Investments II LP

CIK 1357403 · last filed 2015-06-26

Care Capital Offshore Investments II LP is a corporate insider who has filed 27 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing, for ITEK, was dated Jun 26, 2015. Across all open-market trades the lifetime net is −$445.6K, making them a net seller over the disclosed history. The firm reports its address in Princeton, NJ. 58 SEC filings were submitted jointly with CARE CAPITAL INVESTMENTS II LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

27

Lifetime Open-Market Net

-$445.6K

Filer Profile

Reported Address
47 HULFISH STREET
SUITE 310
PRINCETON, NJ 08542
Phone
(609) 683-8300
State of Incorporation
Cayman Islands
Related Filers
CARE CAPITAL INVESTMENTS II LP — 58 joint filings, latest 2015-06-26
CARE CAPITAL II LLC — 56 joint filings, latest 2015-06-26
JAN LESCHLY — 9 joint filings, latest 2006-12-14
David Russ Ramsay — 7 joint filings, latest 2010-03-08
Care Capital III LLC — 4 joint filings, latest 2015-06-26
Care Capital Investments III L.P. — 4 joint filings, latest 2015-06-26
Care Capital Offshore Investments III LP — 4 joint filings, latest 2015-06-26
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted 10%+ Owner 402,437 — — $21.74M 2 2015-06-26
ACURA PHARMACEUTICALS, INC (ACUR) Delisted 10%+ Owner 821,908 — — -$22.18M 23 2014-03-03

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-06-26 ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted Grant (A) — $0 EDGAR
2015-02-25 ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted Mixed +12,372,222 $21.74M EDGAR
2014-03-03 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −693,516 -$1.41M EDGAR
2014-02-26 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −60,096 -$122.6K EDGAR
2013-07-17 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −94,830 -$193.5K EDGAR
2013-07-08 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −42,600 -$85.2K EDGAR
2013-07-03 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −1,743,246 -$4.04M EDGAR
2013-06-24 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −249,000 -$504.4K EDGAR
2013-06-19 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −342,000 -$724.6K EDGAR
2013-06-14 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −270,000 -$583.4K EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.